Priority Efforts to Increase Body’s Immune and The Risk of Covid-19 Clinical Symptoms

Priority Efforts to Increase Body’s Immune and The Risk of Covid-19 Clinical Symptoms
Aliva Global Research and Development
2021-12-11
en
Article
text
People who have been negatively affected by Covid-19 need information on priority efforts to increase their immune system in order to survive in this pandemic era. This cross-sectional survey research aims to find priority efforts among various efforts to prevent the onset of clinical symptoms of Covid-19. We involved 1785 respondents aged 19 years and older by asking them to respond to self-reported online questionnaires distributed throughout Indonesia at March to June 2020. There are 2 data focused on this research, namely efforts to increase body’s immune and clinical symptoms of Covid19 experienced by respondents in the last 14 days. The ordinal-cumulative logit, logistic regression analysis with the assumption of proportional odds, a significance level of 0.05 was used to analyze the data obtained. The results showed that 63% of the people increased their body’s immune in the moderate category and 67.6% of the people experienced clinical symptoms of Covid-19 in the mild category. Rest is the priority effort among several efforts to increase body’s immune. Never rest had a significant effect on clinical symptoms of severe Covid-19 (=-1.014, 95% CI=- 1.480 to -0.547, p = 0.000) and gave 2.756 times the risk compared to those who often rest. Sometimes rest had a significant effect on clinical symptoms of Covid-19 in the moderate category (= -0.464, 95% CI=-0.685 to -0.243, p=0.000) and gave 1.261 times the risk compared to those who often rest. This study concluded that rest is a priority effort that can be made by the community, especially those affected by the Covid-19 pandemic, among the various recommended efforts. The public is still required to implement health protocols and comply with all government policies in order to reduce the number of breakthrough cases and deaths of Covid-19.